Menzel E J, Sobal G, Staudinger A
Institute of Immunology, Vienna, Austria.
Biofactors. 1997;6(2):111-24. doi: 10.1002/biof.5520060204.
Advanced glycation is a major pathway for the posttranslational modification of plasma and tissue proteins. The initiating reaction is the nonenzymatic addition of sugars such as glucose to the primary amino groups of proteins, i.e., mainly to lysine residues. These "early" Schiff base and Amadori products then undergo a series of inter- and intramolecular rearrangements to produce the "late" products termed advanced glycation end products (AGEs). Incubation of LDL with glucose or glucose-6-phosphate produces AGE moieties on both the lipid and apolipoprotein B components. In addition, we tried to generate AGE-LDL by reaction with AGE-peptides (< 10 kD) obtained by enzymatic digestion of long-term glycated fibronectin as a model for connective tissue AGE-peptides. AGE-formation can be assessed by monitoring of fluorescence (370/440 nm) which is easily differentiated from the much lower autofluorescence of oxidized low density lipoproteins (oxLDL). Alternatively, AGE formation was detected by an AGE-specific ELISA using antibodies elicited in rabbits against bovine AGE-RNAse. In the present study we investigated the influence of oxidative stress on the long-term glycation of LDL and the modulation of LDL-oxidation by AGE-modification. We observed (a) that the rate of AGE formation is reduced by BHT/EDTA both on LDL and serum albumin (glycation vs. glycoxidation), (b) long-term glycated LDL is more readily oxidized than unglycated LDL, (c) oxLDL is more prone to AGE-modification, (d) AGE-modification of LDL strongly alters its epitope spectrum and (e) that aminoguanidine at higher concentrations (1-10 mM) inhibits copper-catalyzed LDL oxidation in the way of a classical antioxidant.
晚期糖基化是血浆和组织蛋白翻译后修饰的主要途径。起始反应是糖类(如葡萄糖)非酶促地添加到蛋白质的伯氨基上,即主要添加到赖氨酸残基上。这些“早期”席夫碱和阿马多里产物随后经历一系列分子间和分子内重排,以产生被称为晚期糖基化终产物(AGEs)的“晚期”产物。用葡萄糖或葡萄糖 - 6 - 磷酸孵育低密度脂蛋白(LDL)会在脂质和载脂蛋白B成分上产生AGE部分。此外,我们试图通过与通过长期糖化纤连蛋白的酶促消化获得的AGE肽(<10 kD)反应来生成AGE - LDL,以此作为结缔组织AGE肽的模型。可以通过监测荧光(370/440 nm)来评估AGE的形成,这种荧光很容易与氧化型低密度脂蛋白(oxLDL)低得多的自发荧光区分开来。或者,使用兔抗牛AGE - 核糖核酸酶产生的抗体,通过AGE特异性酶联免疫吸附测定(ELISA)检测AGE的形成。在本研究中,我们研究了氧化应激对LDL长期糖基化的影响以及AGE修饰对LDL氧化的调节作用。我们观察到:(a)丁基羟基甲苯(BHT)/乙二胺四乙酸(EDTA)可降低LDL和血清白蛋白上AGE的形成速率(糖基化与糖氧化);(b)长期糖化的LDL比未糖化的LDL更容易被氧化;(c)oxLDL更容易发生AGE修饰;(d)LDL的AGE修饰强烈改变其表位谱;(e)较高浓度(1 - 10 mM)的氨基胍以经典抗氧化剂的方式抑制铜催化的LDL氧化。